During the past decade, National Institute of Allergy and Infectious Diseases (NIAID) conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Institute of Allergy and Infectious Diseases (NIAID)" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 93 trials, followed by "Center for International Blood and Marrow Transplant Research" with 1 trials sponsored, "Janssen, LP" with 1 trials sponsored, "NeoImmuneTech" with 1 trials sponsored and "Synta Pharmaceuticals Corp." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Institute of Allergy and Infectious Diseases (NIAID)" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "Glaxo Wellcome" with 1 trials as a collaborator, "National Institutes of Health (NIH)" with 1 trials as a collaborator, "National Marrow Donor Program" with 1 trials as a collaborator and "University of Nebraska" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "National Institute of Allergy and Infectious Diseases (NIAID)" are "HIV Infection" (19 trials), "HIV Infections" (14 trials), "Wegener's Granulomatosis" (11 trials), "Acquired Immunodeficiency Syndrome" (10 trials) and "Healthy" (9 trials). Many other conditions were trialed in "National Institute of Allergy and Infectious Diseases (NIAID)" in a lesser frequency.

Most popular intervention types in "National Institute of Allergy and Infectious Diseases (NIAID)" are "Drug" (63 trials), "Procedure" (6 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Interleukin-2" (3 trials), "Voriconazole" (3 trials), "Abacavir" (2 trials), "Amprenavir" (2 trials) and "Interleukin-12" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Institute of Allergy and Infectious Diseases (NIAID)" are 96 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "National Institute of Allergy and Infectious Diseases (NIAID)". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 90 completed trials in National Institute of Allergy and Infectious Diseases (NIAID), undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in National Institute of Allergy and Infectious Diseases (NIAID), 26 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".